Bernard P Roques

USPTO Granted Patents = 27 (Patent Applications = 2)

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 6)

Average Co-Inventor Count = 3.0

ph-index = 7

Forward Citations = 359(Granted Patents)

Location History:

94410 St. Maurice, FR (1986 - 1988)
St. Maurice, FR (1993)
Saint Maurice, FR (1983 - 1996)
Paris, FR (2002 - 2023)

Company Filing History:

12 out of 1,744

Institut National De La Sante Et De La Recherche Medicale

Centre National De La Recherche Scientifique

Université De Technologie De Compiègne

patents

6. 1 out of 20

Societe Civile Bioprojet

patents

7. 1 out of 2

Kos Therapeutics, Inc.

patents

8. 5 out of 832,891

Other

patents

where one patent can have more than one assignee

Years Active: 1983-2025

Loading Chart...

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12485104 - Amino acid derivatives containing a disulfanyl group as an inhibitor of NEP and APN for the prevention and treatment of trigeminal nerve pain (2025-12-02),

2. 11648231 - Amino acid derivatives containing a disulfanyl group in the form of an NEP and APN inhibitor for the prevention and treatment of trigeminal nerve pain (2023-05-16),

3. 10131681 - Aminophosphinic derivatives that can be used in the treatment of pain (2018-11-20),

4. 9388129 - Mixed inhibitors of aminopeptidase N and neprilysin (2016-07-12),

5. 8703747 - Aminophosphinic derivatives that can be used in the treatment of pain (2014-04-22),

6. 8466309 - Amino acid derivatives, method for preparing same, and therapeutic use thereof (2013-06-18),

7. 8247609 - Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase N inhibitors (2012-08-21),

8. 8247608 - Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase N inhibitors (2012-08-21),

9. 7875436 - Peptide substrates recognizable by a botulinum toxin A, BoNT/A and the use thereof (2011-01-25),

10. 7642051 - Screening methods for the identification of inhibitors of human immunodeficiency virus (HIV) viral protein R (Vpr) binding to the adenine nucleotide translocator (ANT) (2010-01-05),

11. 7582797 - Derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulfonates) and compositions comprising the same (2009-09-01),

12. 7235687 - Derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulfphonates) and compositions containing same (2007-06-26),

13. 7205435 - Type B botulism toxin inhibitors (2007-04-17),

14. 7169574 - Fluorescence detection of proteases or peptidases (2007-01-30),

15. 7160982 - Peptide substrate identified by type BoNT/B botulinus toxin and use thereof for assaying and/or detecting said toxin or corresponding inhibitors (2007-01-09),

Certainly! Here is the article about inventor Bernard P Roques:

Title: The Innovative Legacy of Bernard P Roques

Introduction:

Bernard P Roques stands as a beacon of creativity and ingenuity in the world of inventions, with a legacy that continues to inspire future generations of inventors and innovators. His remarkable contributions in the field of pharmaceuticals have paved the way for groundbreaking advancements in pain management and treatment.

Latest Patents:

Bernard P Roques holds an impressive total of 26 patents, with his latest inventions focusing on cutting-edge pharmaceutical developments. One of his recent patents involves amino acid derivatives containing a disulfanyl group, designed as NEP and APN inhibitors for the prevention and treatment of trigeminal nerve pain, particularly migraines or trigeminal neuralgia. Another notable patent showcases aminophosphinic derivatives for the treatment of pain, especially neuropathic and neuroinflammatory pain.

Career Highlights:

Throughout his illustrious career, Bernard P Roques has made significant contributions while working with prestigious organizations such as the Institut National De La Sante Et De La Recherche Medicale (Inserm) and Pharmaleads. His expertise and dedication have been instrumental in advancing the field of pharmaceutical research and development.

Collaborations:

Bernard P Roques has collaborated with esteemed professionals in the industry, including Marie-Claude Fournie-Zaluski and Jeanne-Marie Lecomte. Together, they have spearheaded innovative projects and research initiatives that have led to groundbreaking discoveries in the realm of pain management and treatment.

Conclusion:

In conclusion, Bernard P Roques' passion for innovation and his relentless pursuit of excellence have cemented his legacy as a pioneering inventor in the pharmaceutical industry. His revolutionary patents and collaborative efforts continue to shape the future of healthcare, making him a true trailblazer in the world of inventions and innovations.

This text is generated by artificial intelligence and may not be accurate.